Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15913 | 684 | 42.0 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
1549 | 2 | CYCLOTIDES//BOWMAN BIRK INHIBITOR//TRYPSIN INHIBITOR | 7414 |
15913 | 1 | MATRIPTASE//CORIN//HEPSIN | 684 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MATRIPTASE | authKW | 2928867 | 12% | 81% | 81 |
2 | CORIN | authKW | 1157075 | 5% | 72% | 36 |
3 | HEPSIN | authKW | 1153064 | 5% | 70% | 37 |
4 | HAI 1 | authKW | 1033353 | 4% | 93% | 25 |
5 | TYPE II TRANSMEMBRANE SERINE PROTEASE | authKW | 1005904 | 4% | 87% | 26 |
6 | TMPRSS4 | authKW | 811651 | 3% | 91% | 20 |
7 | HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1 | authKW | 535692 | 2% | 100% | 12 |
8 | HAI 2 | authKW | 405826 | 1% | 91% | 10 |
9 | PROSTASIN | authKW | 361572 | 3% | 45% | 18 |
10 | PROTEASES TISSUE REMODELING UNIT | address | 330782 | 2% | 44% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1394 | 39% | 0% | 267 |
2 | Oncology | 1194 | 23% | 0% | 157 |
3 | Cell Biology | 866 | 20% | 0% | 134 |
4 | Pathology | 170 | 5% | 0% | 35 |
5 | Chemistry, Medicinal | 139 | 5% | 0% | 34 |
6 | Biophysics | 104 | 6% | 0% | 38 |
7 | Urology & Nephrology | 75 | 4% | 0% | 26 |
8 | Physiology | 71 | 5% | 0% | 31 |
9 | Peripheral Vascular Diseases | 60 | 4% | 0% | 24 |
10 | Developmental Biology | 32 | 2% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROTEASES TISSUE REMODELING UNIT | 330782 | 2% | 44% | 17 |
2 | PROTEASES TISSUE REMODELING SECT | 301697 | 2% | 48% | 14 |
3 | SECT ONCOPATHOL REGENERAT BIOL | 234545 | 2% | 31% | 17 |
4 | ENZYME CHEMSAKYO KU | 229581 | 1% | 86% | 6 |
5 | LOMBARDI CANC COMPREHENS | 133923 | 0% | 100% | 3 |
6 | ORAL PHARYNGEAL CANC BRANCH | 104296 | 5% | 7% | 35 |
7 | KIADB IND AREA 39 40 | 89282 | 0% | 100% | 2 |
8 | LAMBARDI COMPREHENS CANC | 89282 | 0% | 100% | 2 |
9 | MOL CARDIOL NEPHROL HYPERTENS | 89282 | 0% | 100% | 2 |
10 | CYRUS TANG HEMATOL | 77468 | 3% | 8% | 21 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN CELL | 5833 | 1% | 3% | 5 |
2 | PROSTATE | 1396 | 2% | 0% | 12 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1206 | 10% | 0% | 66 |
4 | BIOLOGICAL CHEMISTRY | 1116 | 1% | 0% | 9 |
5 | FRONTIERS IN BIOSCIENCE-LANDMARK | 997 | 1% | 0% | 9 |
6 | AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 876 | 2% | 0% | 12 |
7 | AMERICAN JOURNAL OF PATHOLOGY | 671 | 2% | 0% | 14 |
8 | CANCER SCIENCE | 609 | 1% | 0% | 7 |
9 | JACC-HEART FAILURE | 597 | 0% | 1% | 2 |
10 | BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 581 | 1% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MATRIPTASE | 2928867 | 12% | 81% | 81 | Search MATRIPTASE | Search MATRIPTASE |
2 | CORIN | 1157075 | 5% | 72% | 36 | Search CORIN | Search CORIN |
3 | HEPSIN | 1153064 | 5% | 70% | 37 | Search HEPSIN | Search HEPSIN |
4 | HAI 1 | 1033353 | 4% | 93% | 25 | Search HAI+1 | Search HAI+1 |
5 | TYPE II TRANSMEMBRANE SERINE PROTEASE | 1005904 | 4% | 87% | 26 | Search TYPE+II+TRANSMEMBRANE+SERINE+PROTEASE | Search TYPE+II+TRANSMEMBRANE+SERINE+PROTEASE |
6 | TMPRSS4 | 811651 | 3% | 91% | 20 | Search TMPRSS4 | Search TMPRSS4 |
7 | HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1 | 535692 | 2% | 100% | 12 | Search HEPATOCYTE+GROWTH+FACTOR+ACTIVATOR+INHIBITOR+1 | Search HEPATOCYTE+GROWTH+FACTOR+ACTIVATOR+INHIBITOR+1 |
8 | HAI 2 | 405826 | 1% | 91% | 10 | Search HAI+2 | Search HAI+2 |
9 | PROSTASIN | 361572 | 3% | 45% | 18 | Search PROSTASIN | Search PROSTASIN |
10 | TTSP | 312487 | 1% | 100% | 7 | Search TTSP | Search TTSP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANTALIS, TM , BUGGE, TH , WU, QY , (2011) MEMBRANE-ANCHORED SERINE PROTEASES IN HEALTH AND DISEASE.PROTEASES IN HEALTH AND DISEASE. VOL. 99. ISSUE . P. 1 -50 | 165 | 62% | 20 |
2 | MURRAY, AS , VARELA, FA , LIST, K , (2016) TYPE II TRANSMEMBRANE SERINE PROTEASES AS POTENTIAL TARGETS FOR CANCER THERAPY.BIOLOGICAL CHEMISTRY. VOL. 397. ISSUE 9. P. 815 -826 | 101 | 86% | 0 |
3 | ANTALIS, TM , BUZZA, MS , HODGE, KM , HOOPER, JD , NETZEL-ARNETT, S , (2010) THE CUTTING EDGE: MEMBRANE-ANCHORED SERINE PROTEASE ACTIVITIES IN THE PERICELLULAR MICROENVIRONMENT.BIOCHEMICAL JOURNAL. VOL. 428. ISSUE . P. 325-346 | 128 | 56% | 39 |
4 | SZABO, R , BUGGE, TH , (2008) TYPE II TRANSMEMBRANE SERINE PROTEASES IN DEVELOPMENT AND DISEASE.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 40. ISSUE 6-7. P. 1297-1316 | 106 | 66% | 84 |
5 | LIST, K , (2009) MATRIPTASE: A CULPRIT IN CANCER?.FUTURE ONCOLOGY. VOL. 5. ISSUE 1. P. 97-104 | 56 | 93% | 33 |
6 | WEBB, SL , SANDERS, AJ , MASON, MD , JIANG, WG , (2011) TYPE II TRANSMEMBRANE SERINE PROTEASE (TTSP) DEREGULATION IN CANCER.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 16. ISSUE . P. 539 -552 | 75 | 65% | 18 |
7 | FRIIS, S , SALES, KU , SCHAFER, JM , VOGEL, LK , KATAOKA, H , BUGGE, TH , (2014) THE PROTEASE INHIBITOR HAI-2, BUT NOT HAI-1, REGULATES MATRIPTASE ACTIVATION AND SHEDDING THROUGH PROSTASIN.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 289. ISSUE 32. P. 22319 -22332 | 47 | 87% | 5 |
8 | BERGUM, C , LIST, K , (2010) LOSS OF THE MATRIPTASE INHIBITOR HAI-2 DURING PROSTATE CANCER PROGRESSION.PROSTATE. VOL. 70. ISSUE 13. P. 1422-1428 | 40 | 95% | 11 |
9 | CHU, LL , XU, Y , YANG, JR , HU, YA , CHANG, HH , LAI, HY , TSENG, CC , WANG, HY , JOHNSON, MD , WANG, JK , ET AL (2014) HUMAN CANCER CELLS RETAIN MODEST LEVELS OF ENZYMATICALLY ACTIVE MATRIPTASE ONLY IN EXTRACELLULAR MILIEU FOLLOWING INDUCTION OF ZYMOGEN ACTIVATION.PLOS ONE. VOL. 9. ISSUE 3. P. - | 40 | 87% | 2 |
10 | SZABO, R , KOSA, P , LIST, K , BUGGE, TH , (2009) LOSS OF MATRIPTASE SUPPRESSION UNDERLIES SPINT1 MUTATION-ASSOCIATED ICHTHYOSIS AND POSTNATAL LETHALITY.AMERICAN JOURNAL OF PATHOLOGY. VOL. 174. ISSUE 6. P. 2015-2022 | 40 | 93% | 23 |
Classes with closest relation at Level 1 |